Holen Sie sich die Stockscreener-App
1.84
2.13%
-0.04
Handel nachbörslich:
1.83
-0.01
-0.54%
Schlusskurs vom Vortag:
$1.88
Offen:
$1.99
24-Stunden-Volumen:
408.20K
Relative Volume:
0.95
Marktkapitalisierung:
$247.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-4.973
EPS:
-0.37
Netto-Cashflow:
$-42.28M
1W Leistung:
+15.72%
1M Leistung:
+16.46%
6M Leistung:
-7.07%
1J Leistung:
-6.60%
1-Tages-Spanne:
$1.72
$1.99
1-Wochen-Bereich:
$1.58
$1.99
52-Wochen-Spanne:
$0.765
$2.34
Compass Therapeutics Inc Stock (CMPX) Company Profile
Firmenname
Compass Therapeutics Inc
Sektor
Branche
Telefon
617-500-8099
Adresse
80 GUEST STREET, BOSTON
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-31 | Eingeleitet | Jefferies | Buy |
| 2023-01-27 | Eingeleitet | Stifel | Buy |
| 2022-05-23 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-03-15 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-01-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Raymond James | Outperform |
| 2021-12-20 | Eingeleitet | SVB Leerink | Outperform |
| 2021-12-15 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat
Rhumbline Advisers Takes Position in Perma-Fix Environmental Services, Inc. (NASDAQ:PESI) - Defense World
Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World
PCM Fund Inc. (NYSE:PCM) Short Interest Down 36.3% in September - Defense World
Federated Hermes Inc. Has $51,000 Holdings in Deluxe Co. (NYSE:DLX) - Defense World
Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR
Was anything positive for Compass Therapeutics Inc (CMPX) stock last session? - US Post News
Compass Therapeutics Inc Inc. (CMPX) Price Performance: The Role of Supply and Demand - The InvestChronicle
TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail
Compass Diversified (NYSE:CODI) Insider Acquires $109,350.00 in Stock - Defense World
Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Oppenheimer Asset Management Inc. Invests $195,000 in Compass Minerals International, Inc. (NYSE:CMP) - Defense World
Compass, Inc. (NYSE:COMP) Short Interest Down 6.0% in August - Defense World
Excalibur (Cayman) Ltd Svf Sells 7,500,000 Shares of Compass, Inc. (NYSE:COMP) Stock - Defense World
A stock that deserves closer examination: Compass Therapeutics Inc (CMPX) - US Post News
Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) - MSN
Head-To-Head Analysis: Galera Therapeutics (NASDAQ:GRTX) & Galectin Therapeutics (NASDAQ:GALT) - Defense World
Ladenburg raises Compass Therapeutics shares to Buy rating with no target change - Investing.com Canada
Compass Therapeutics (NASDAQ:CMPX) Lifted to Buy at LADENBURG THALM/SH SH - MarketBeat
Executive team - Compass Pathways
National Bank of Canada FI Boosts Position in VICI Properties Inc. (NYSE:VICI) - Defense World
Upward Trajectory: Compass Therapeutics Inc (CMPX) Posts a Slidee, Closing at 1.49 - The Dwinnex
Enphase Energy, Inc. (NASDAQ:ENPH) Shares Sold by Panagora Asset Management Inc. - Defense World
Panagora Asset Management Inc. Invests $323,000 in Ring Energy, Inc. (NYSEAMERICAN:REI) - Defense World
Fox Co. (NASDAQ:FOXA) Shares Sold by Panagora Asset Management Inc. - Defense World
Genworth Financial, Inc. (NYSE:GNW) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Tobam Has $3.27 Million Position in Meta Platforms, Inc. (NASDAQ:META) - Defense World
Panagora Asset Management Inc. Lowers Stake in Quad/Graphics, Inc. (NYSE:QUAD) - Defense World
Bank of New York Mellon Corp Acquires 22,310 Shares of ICU Medical, Inc. (NASDAQ:ICUI) - Defense World
Panagora Asset Management Inc. Purchases New Stake in Wingstop Inc. (NASDAQ:WING) - Defense World
Panagora Asset Management Inc. Sells 2,087 Shares of MSA Safety Incorporated (NYSE:MSA) - Defense World
Compass Therapeutics, Inc. (CMPX) Upgraded to Buy: Here's Why - Yahoo Finance UK
Compass Therapeutics Inc (CMPX) presents a great opportunity, but the stock is slightly undervalued - US Post News
CMPX: A Tale of Ups & Downs – -16.84% loss in 6 Months, 58.62% in 30 Days - The InvestChronicle
Compass Therapeutics to Participate in Upcoming Investor Events - GlobeNewswire
Compass Therapeutics to Participate in Upcoming Investor Events - Yahoo Finance
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - Defense World
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat
CMPX’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Eliem Therapeutics appoints new COO Brett Kaplan - Investing.com
Eliem Therapeutics Announces Additions to its Leadership Team - ForexTV.com
Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire
Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire Inc.
Financial Comparison: Voyager Therapeutics (NASDAQ:VYGR) versus Compass Therapeutics (NASDAQ:CMPX) - Defense World
Institutional investors own a significant stake of 50% in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Yahoo Finance
Compass Therapeutics, Inc. (NASDAQ:CMPX) Sees Large Decrease in Short Interest - MarketBeat
Q3 2024 EPS Estimates for Abeona Therapeutics Inc Cut by Analyst (NASDAQ:ABEO) - Defense World
Compass Therapeutics, Inc. to Post Q3 2024 Earnings of ($0.11) Per Share, Wedbush Forecasts (NASDAQ:CMPX) - Defense World
Wedbush Weighs in on Compass Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:CMPX) - MarketBeat
Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Acquired by Vanguard Group Inc. - Defense World
FY2024 EPS Estimates for Centric Health Corp. (TSE:CRX) Decreased by Cormark - Defense World
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):